Rebecca C.E. McFadyen

A registered patent lawyer with an advanced degree in biomedical sciences (neuroscience), Rebecca McFadyen has experience in all aspects of domestic and international patent prosecution (including third-party preissuance submissions), client counseling, and pre-litigation analysis relating to the life sciences and biotechnology technical areas. She works with clients to review, analyze, and evaluate intellectual property (IP)-related issues to provide a comprehensive overview of the IP portfolio.

Rebecca focuses her practice on a variety of technologies including DNA and protein therapeutics, biomarkers, genetic engineering, transgenic animals, gene therapy, molecular and cellular biological screening assays, vaccines, peptide/protein therapy and diagnostics, lipid fermentation, nucleic acid amplification, and various biotechnical research tools.

In addition, Rebecca prepares and renders non-infringement, invalidity, and freedom-to-operate opinions.

Subscribe to all posts by Rebecca C.E. McFadyen

Adjustments to Copyright Act Timing Provisions for Applicants Affected by COVID-19

On March 27, 2020, the President signed into law the Coronavirus Aid, Relief, and Economic Security (CARES) Act, which added § 710 to the Copyright Act. § 710 explains that if the Register of Copyrights determines that a declared national emergency “generally disrupts or suspends the ordinary functioning of the copyright system… or any component thereof,” then the Register … Continue Reading

LexBlog